Epidemiology and Evolution of Rotaviruses and Noroviruses from an Archival WHO Global Study in Children (1976-79) with Implications for Vaccine Design

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Rackoff, Lauren A ^a   Bok, Karin ^a   Green, Kim Y ^a   Kapikian, Albert Z ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VACCINE;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CHILD; CONTROLLED STUDY; DRUG DESIGN; FECES ANALYSIS; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MICROBIAL DIVERSITY; MOLECULAR EPIDEMIOLOGY; MOLECULAR EVOLUTION; MOLECULAR PHYLOGENY; NONHUMAN; NOROVIRUS; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; PRESCHOOL CHILD; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ROTAVIRUS; SEQUENCE ANALYSIS; VIRAL GASTROENTERITIS; VIRUS DETECTION; VIRUS GENOME; VIRUS IDENTIFICATION; VIRUS STRAIN;

ADOLESCENT; ANTIGENS, VIRAL; CAPSID PROTEINS; CHILD; CHILD, PRESCHOOL; DIARRHEA; EVOLUTION, MOLECULAR; GASTROENTERITIS; GENOTYPE; HISTORY, 20TH CENTURY; HUMANS; INFANT; INFANT, NEWBORN; MOLECULAR SEQUENCE DATA; NOROVIRUS; PHYLOGENY; ROTAVIRUS; VIRAL VACCINES; WORLD HEALTH;

NORWALK VIRUS; ROTAVIRUS;

EID: 84875469105     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059394     Document Type: Article

References (61)

1. Black RE, Cousens S, Johnson HL, Lawn JE, Rudan I, et al. (2010) Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet 375: 1969-1987.
2. Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, et al. (2011) 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis.
3. Patel MM, Widdowson MA, Glass RI, Akazawa K, Vinje J, et al. (2008) Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg Infect Dis 14: 1224-1231.
4. Estes MK, Kapikian AZ (2007) Rotaviruses. In: Knipe DM, Howley PM, editors. Fields Virology. 5th ed. Philadelphia: Lippincott Williams & Wilkins. 1918-1974.
5. Matthijnssens J, Ciarlet M, McDonald SM, Attoui H, Banyai K, et al. (2011) Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Arch Virol 156: 1397-1413.
6. Santos N, Hoshino Y, (2005) Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol 15: 29-56.
7. Santos N, Volotao EM, Soares CC, Campos GS, Sardi SI, et al. (2005) Predominance of rotavirus genotype G9 during the 1999, 2000, and 2002 seasons among hospitalized children in the city of Salvador, Bahia, Brazil: implications for future vaccine strategies. J Clin Microbiol 43: 4064-4069.
8. Matthijnssens J, Heylen E, Zeller M, Rahman M, Lemey P, et al. (2010) Phylodynamic analyses of rotavirus genotypes G9 and G12 underscore their potential for swift global spread. Mol Biol Evol 27: 2431-2436.
9. Banyai K, Laszlo B, Duque J, Steele AD, Nelson EA, et al. (2012) Systematic review of regional and temporal trends in global rotavirus strain diversity in the pre rotavirus vaccine era: insights for understanding the impact of rotavirus vaccination programs. Vaccine 30Suppl 1: A122-130.
10. Tate JE, Patel MM, Steele AD, Gentsch JR, Payne DC, et al. (2010) Global impact of rotavirus vaccines. Expert Rev Vaccines 9: 395-407.
11. Armah GE, Sow SO, Breiman RF, Dallas MJ, Tapia MD, et al. (2010) Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet 376: 606-614.
12. Green KY (2007) Noroviruses. In: Knipe DM, Howley PM, editors. Fields Virology. 5th ed. Philadelphia: Lippincott Williams & Wilkins. 949-979.
13. Zheng DP, Ando T, Fankhauser RL, Beard RS, Glass RI, et al. (2006) Norovirus classification and proposed strain nomenclature. Virology 346: 312-323.
14. Siebenga JJ, Vennema H, Duizer E, Koopmans MP, (2007) Gastroenteritis caused by norovirus GGII.4, The Netherlands, 1994-2005. Emerg Infect Dis 13: 144-146.
15. Kroneman A, Verhoef L, Harris J, Vennema H, Duizer E, et al. (2008) Analysis of integrated virological and epidemiological reports of norovirus outbreaks collected within the Foodborne Viruses in Europe network from 1 July 2001 to 30 June 2006. J Clin Microbiol 46: 2959-2965.
16. Gallimore CI, Green J, Lewis D, Richards AF, Lopman BA, et al. (2004) Diversity of noroviruses cocirculating in the north of England from 1998 to 2001. J Clin Microbiol 42: 1396-1401.
17. Kapikian AZ, Wyatt RG, Dolin R, Thornhill TS, Kalica AR, et al. (1972) Visualization by immune electron microscopy of a 27-nm particle associated with acute infectious nonbacterial gastroenteritis. J Virol 10: 1075-1081.
18. Bishop RF, Davidson GP, Holmes IH, Ruck BJ, (1973) Letter: Evidence for viral gastroenteritis. N Engl J Med 289: 1096-1097.
19. National̂Institutêof̂Allergŷand̂InfectiouŝDiseaseŝ(U.S.A.) (1979) Annual Report of Program Activities National Institute of Allergy and Infectious Diseases Fiscal Year 1979. Washington, D. C.: Government Printing Office.
20. Yolken RH, (1980) Enzyme-linked immunosorbent assay (ELISA): a practical tool for rapid diagnosis of viruses and other infectious agents. Yale J Biol Med 53: 85-92.
21. Based on a Report of a Sub-group of the Scientific Working Group on Epidemiology and Etiology CDD Programme in 1979 (1980) Rotavirus and other viral diarrhoeas: WHO scientific working group. Bull World Health Organ 58: 183-198.
22. Greenberg HB, Wyatt RG, Valdesuso J, Kalica AR, London WT, et al. (1978) Solid-phase microtiter radioimmunoassay for detection of the Norwalk strain of acute nonbacterial, epidemic gastroenteritis virus and its antibodies. J Med Virol 2: 97-108.
23. Zeng SQ, Halkosalo A, Salminen M, Szakal ED, Puustinen L, et al. (2008) One-step quantitative RT-PCR for the detection of rotavirus in acute gastroenteritis. J Virol Methods 153: 238-240.
24. Vinje J, Hamidjaja RA, Sobsey MD, (2004) Development and application of a capsid VP1 (region D) based reverse transcription PCR assay for genotyping of genogroup I and II noroviruses. J Virol Methods 116: 109-117.
25. Jiang X, Huang PW, Zhong WM, Farkas T, Cubitt DW, et al. (1999) Design and evaluation of a primer pair that detects both Norwalk- and Sapporo-like caliciviruses by RT-PCR. J Virol Methods 83: 145-154.
26. Das BK, Gentsch JR, Cicirello HG, Woods PA, Gupta A, et al. (1994) Characterization of rotavirus strains from newborns in New Delhi, India. J Clin Microbiol 32: 1820-1822.
27. Gouvea V, Santos N, Timenetsky Mdo C, (1994) Identification of bovine and porcine rotavirus G types by PCR. J Clin Microbiol 32: 1338-1340.
28. Gentsch JR, Glass RI, Woods P, Gouvea V, Gorziglia M, et al. (1992) Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol 30: 1365-1373.
29. Gouvea V, Glass RI, Woods P, Taniguchi K, Clark HF, et al. (1990) Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J Clin Microbiol 28: 276-282.
30. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, et al. (2007) Clustal W and Clustal X version 2.0. Bioinformatics 23: 2947-2948.
31. Posada D, Crandall KA, (1998) MODELTEST: testing the model of DNA substitution. Bioinformatics 14: 817-818.
32. Guindon S, Dufayard JF, Lefort V, Anisimova M, Hordijk W, et al. (2010) New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst Biol 59: 307-321.
33. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, et al. (2011) MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28: 2731-2739.
34. Drummond AJ, Rambaut A, (2007) BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol 7: 214.
35. Drummond AJ, Rambaut A, Shapiro B, Pybus OG, (2005) Bayesian coalescent inference of past population dynamics from molecular sequences. Mol Biol Evol 22: 1185-1192.
36. Drummond AJ, Ho SY, Phillips MJ, Rambaut A, (2006) Relaxed phylogenetics and dating with confidence. PLoS Biol 4: e88.
37. Todd S, Page NA, Duncan Steele A, Peenze I, Cunliffe NA, (2010) Rotavirus strain types circulating in Africa: Review of studies published during 1997-2006. J Infect Dis 202Suppl: S34-42.
38. Gouvea V, de Castro L, Timenetsky MC, Greenberg H, Santos N, (1994) Rotavirus serotype G5 associated with diarrhea in Brazilian children. J Clin Microbiol 32: 1408-1409.
39. da Silva MF, Tort LF, Gomez MM, Assis RM, Volotao Ede M, et al. (2011) VP7 Gene of human rotavirus A genotype G5: Phylogenetic analysis reveals the existence of three different lineages worldwide. J Med Virol 83: 357-366.
40. Cook N, Bridger J, Kendall K, Gomara MI, El-Attar L, et al. (2004) The zoonotic potential of rotavirus. J Infect 48: 289-302.
41. Stupka JA, Parra GI, Gomez J, Arbiza J, (2007) Detection of human rotavirus G9P[8] strains circulating in Argentina: phylogenetic analysis of VP7 and NSP4 genes. J Med Virol 79: 838-842.
42. Martinez-Laso J, Roman A, Head J, Cervera I, Rodriguez M, et al. (2009) Phylogeny of G9 rotavirus genotype: a possible explanation of its origin and evolution. J Clin Virol 44: 52-57.
43. Zheng DP, Widdowson MA, Glass RI, Vinje J, (2010) Molecular epidemiology of genogroup II-genotype 4 noroviruses in the United States between 1994 and 2006. J Clin Microbiol 48: 168-177.
44. Drafted by signatories of a meeting of the Scientific Working Group on Immunity and Vaccine Development in 1978 (1979) Intestinal immunity and vaccine development: a WHO memorandum. Bull World Health Organ 57: 719-734.
45. Gorziglia M, Green K, Nishikawa K, Taniguchi K, Jones R, et al. (1988) Sequence of the fourth gene of human rotaviruses recovered from asymptomatic or symptomatic infections. J Virol 62: 2978-2984.
46. Hoshino Y, Jones RW, Ross J, Honma S, Santos N, et al. (2004) Rotavirus serotype G9 strains belonging to VP7 gene phylogenetic sequence lineage 1 may be more suitable for serotype G9 vaccine candidates than those belonging to lineage 2 or 3. J Virol 78: 7795-7802.
47. Boon D, Mahar JE, Abente EJ, Kirkwood CD, Purcell RH, et al. (2011) Comparative evolution of GII.3 and GII.4 norovirus over a 31-year period. J Virol 85: 8656-8666.
48. Bok K, Abente EJ, Realpe-Quintero M, Mitra T, Sosnovtsev SV, et al. (2009) Evolutionary dynamics of GII.4 noroviruses over a 34-year period. J Virol 83: 11890-11901.
49. Martella V, Campolo M, Lorusso E, Cavicchio P, Camero M, et al. (2007) Norovirus in captive lion cub (Panthera leo). Emerg Infect Dis 13: 1071-1073.
50. Duffy S, Shackelton LA, Holmes EC, (2008) Rates of evolutionary change in viruses: patterns and determinants. Nat Rev Genet 9: 267-276.
51. Patton JT, (2012) Rotavirus diversity and evolution in the post-vaccine world. Discov Med 13: 85-97.
52. Patel MM, Glass R, Desai R, Tate JE, Parashar UD, (2012) Fulfilling the promise of rotavirus vaccines: how far have we come since licensure? Lancet Infect Dis 12: 561-570.
53. Vesikari T, (2012) Rotavirus vaccination: a concise review. Clin Microbiol Infect 18Suppl 5: 57-63.
54. Vesikari T, Karvonen AV, Majuri J, Zeng SQ, Pang XL, et al. (2006) Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children. J Infect Dis 194: 370-376.
55. Atmar RL, Bernstein DI, Harro CD, Al-Ibrahim MS, Chen WH, et al. (2011) Norovirus vaccine against experimental human Norwalk Virus illness. N Engl J Med 365: 2178-2187.
56. Parra GI, Bok K, Taylor R, Haynes JR, Sosnovtsev SV, et al. (2012) Immunogenicity and specificity of norovirus Consensus GII.4 virus-like particles in monovalent and bivalent vaccine formulations. Vaccine 30: 3580-3586.
57. Tan M, Jiang X, (2012) Norovirus P particle: a subviral nanoparticle for vaccine development against norovirus, rotavirus and influenza virus. Nanomedicine (Lond) 7: 889-897.
58. Ramirez K, Wahid R, Richardson C, Bargatze RF, El-Kamary SS, et al. (2012) Intranasal vaccination with an adjuvanted Norwalk virus-like particle vaccine elicits antigen-specific B memory responses in human adult volunteers. Clin Immunol 144: 98-108.
59. Atmar RL, Estes MK, (2012) Norovirus vaccine development: next steps. Expert Rev Vaccines 11: 1023-1025.
60. Lindesmith LC, Beltramello M, Donaldson EF, Corti D, Swanstrom J, et al. (2012) Immunogenetic mechanisms driving norovirus GII.4 antigenic variation. PLoS Pathog 8: e1002705.
61. Wyatt RG, Dolin R, Blacklow NR, DuPont HL, Buscho RF, et al. (1974) Comparison of three agents of acute infectious nonbacterial gastroenteritis by cross-challenge in volunteers. J Infect Dis 129: 709-714.